NOS1 antibody (AA 1422-1433)
Quick Overview for NOS1 antibody (AA 1422-1433) (ABIN2771000)
Target
See all NOS1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 1422-1433
 - 
                                            
Purpose
 - NNOS / NOS Rabbit anti-Human Polyclonal (aa1422-1433) (Unconjugated) Antibody, (100ul)
 - 
                                            
Purification
 - Immunoaffinity Chromatography
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - ICC, IHC-P (5 µ,g/mL), IP, WB
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Concentration
 - 0.4 mg/mL
 - 
                                            
Buffer
 - TBS, pH 7.4, 0.5 mg/mL BSA, 50 % glycerol, 0.02 % sodium azide.
 - 
                                            
Preservative
 - Sodium azide
 - 
                                            
Precaution of Use
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 2-8°C (short-term), -20°C (long-term)
 
 - 
                                            
 - 
    
- NOS1 (Nitric Oxide Synthase 1, Neuronal (NOS1))
 - 
                                            
Alternative Name
 - NNOS / NOS
 - 
                                            
Background
 - 
                        
Gene Symbol: NOS1
 - 
                                            
Gene ID
 - 4842
 - 
                                            
UniProt
 - P29475
 - 
                                            
Pathways
 - Negative Regulation of Hormone Secretion, Myometrial Relaxation and Contraction
 
Target
 -